Mr. Rashed Assouma, CEO of Elis Pharmaceuticals, commented that the Elis Pharmaceuticals' exhibition stand is spacious enough to accommodate a large number of guests and visitors for Elis business presentations.
Assouma said:
"We will also be launching our latest breakthrough product, Clarastill eye drop solution that specifically prevents and treats cataract. Clarastill is manufactured in Italy and this drug will transform millions of patients' lives who currently suffer from cataract, which itself is leading cause of blindness in the world today - particularly in the third world countries. Another new Elis product being presented at the exhibition is Apeaz, a USFDA approved fast acting and powerful arthritis cream. This drug has the highest potency and tissue regeneration."
Mr Assouma is confident that this event is the perfect platform for launching new CE and FDA approved products in the region.
Browse
related articles

Posted by Siba Sami Ammari
